Theravance Biopharma Inc (TBPH) — Cash Flow Quality Index
Theravance Biopharma Inc (TBPH) has a Cash Flow Quality Index of -0.10x as of December 2025. Operating cash flow of $-6.06 Million is below net income of $61.02 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore TBPH strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Theravance Biopharma Inc Cash Flow Quality Index (2025–2025)
Historical Cash Flow Quality Index for Theravance Biopharma Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Theravance Biopharma Inc (TBPH) tangible net worth to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Theravance Biopharma Inc (2025–2025)
Year-by-year earnings quality comparison for Theravance Biopharma Inc. For live market cap and the full company financial profile, see Theravance Biopharma Inc market capitalisation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.25x | $238.54 Million | $105.89 Million | — |